5 research outputs found

    Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs

    No full text
    <div><p>microRNAs have emerged as powerful regulators of many biological processes, and their expression in many cancer tissues has been shown to correlate with clinical parameters such as cancer type and prognosis. Present in a variety of biological fluids, microRNAs have been described as a ‘gold mine’ of potential noninvasive biomarkers. Release of microRNA content of blood cells upon hemolysis dramatically alters the microRNA profile in blood, potentially affecting levels of a significant number of proposed biomarker microRNAs and, consequently, accuracy of serum or plasma-based tests. Several methods to detect low levels of hemolysis have been proposed; however, a direct comparison assessing their sensitivities is currently lacking. In this study, we evaluated the sensitivities of four methods to detect hemolysis in serum (listed in the order of sensitivity): measurement of hemoglobin using a Coulter® AcT diff™ Analyzer, visual inspection, the absorbance of hemoglobin measured by spectrophotometry at 414 nm and the ratio of red blood cell-enriched miR-451a to the reference microRNA miR-23a-3p. The miR ratio detected hemolysis down to approximately 0.001%, whereas the Coulter® AcT diff™ Analyzer was unable to detect hemolysis lower than 1%. The spectrophotometric method could detect down to 0.004% hemolysis, and correlated with the miR ratio. Analysis of hemolysis in a cohort of 86 serum samples from cancer patients and healthy controls showed that 31 of 86 (36%) were predicted by the miR ratio to be hemolyzed, whereas only 8 of these samples (9%) showed visible pink discoloration. Using receiver operator characteristic (ROC) analyses, we identified absorbance cutoffs of 0.072 and 0.3 that could identify samples with low and high levels of hemolysis, respectively. Overall, this study will assist researchers in the selection of appropriate methodologies to test for hemolysis in serum samples prior to quantifying expression of microRNAs.</p></div

    Assessment of performance of the spectrophotometric absorbance of hemoglobin at 414 nm for predicting the miR ratio.

    No full text
    <p>Assessment of performance of the spectrophotometric absorbance of hemoglobin at 414 nm for predicting the miR ratio.</p

    Sensitivities of four methods to detect hemolysis.

    No full text
    <p><b>(A)</b> A hemolysis series was prepared by diluting 100% hemolyzed sample with unhemolyzed serum (0%), and the sensitivity of each method determined by its ability to detect hemolysis (indicated by arrows). <b>(B—E)</b> Detection of hemolysis using four methods. For visual inspection, samples were scored from 0 (unhemolyzed sample) to 5 (100% hemolysis). Averages of technical replicates are shown where appropriate. ‘Unhem’ denotes unhemolyzed serum. Absorbance measures (D) and miR ratios (E) are noted on the graphs.</p

    Hemolysis-sensitive high and low abundant microRNAs are significantly altered between categories defined by the miR ratio.

    No full text
    <p><b>(A)</b> Levels of hemolysis-sensitive highly abundant serum microRNA miR−16−5p was found to be significantly altered across low, moderate and severely hemolyzed serum samples defined by miR ratios <b>(B)</b> Levels of a hemolysis-sensitive low abundant microRNA miR−15b−3p were also different across all miR ratio categories. <b>(C)</b> miR−23a−3p was present at a similar level amongst three categories, supporting its use as a reference microRNA in determining the miR ratio. * <i>P</i> <0.05, ** <i>P</i> < 0.001 and *** <i>P</i> < 0.0001.</p

    Assessment of hemolysis in serum samples.

    No full text
    <p>All serum samples exhibiting pink discoloration were found to be strongly affected by hemolysis for microRNA profiling according to the miR ratio. After exclusion of the visibly hemolyzed samples, samples with absorbance at 414 nm of >0.3 are also likely to be have miR ratio >7, predicting severe hemolysis. In contrast, samples with an absorbance at 414 nm of <0.072 are predicted to have a miR ratio <5. Samples meeting these criteria may be excluded from miR ratio for the purpose of determining hemolysis; however, the miR ratio should be determined for samples with absorbance between 0.072 and 0.3. PPV and NPV refer to positive and negative predictive values after removal of visibly hemolyzed or cloudy samples, respectively.</p
    corecore